Bryn Martin

Bryn Martin, Ph.D., currently serves as Vice President of Research, Drug Delivery, and CSF Sciences at Alcyone Therapeutics Inc. since 2017, while also holding positions as a Scientific Advisory Board Member for several organizations, including Novoron Bioscience, Anuncia Inc., and the Bobby Jones Chiari & Syringomyelia Foundation. In addition to these roles, Bryn Martin is an Adjunct Associate Professor of Mechanical, Chemical, and Biological Engineering at the University of Idaho and a Principal Officer at Flux Neuroscience, LLC. Bryn Martin contributes as an Associate Editor for Fluids and Barriers of the CNS and has held joint faculty positions at the California Institute of Neuroscience and the University of Washington - School of Medicine. Educational credentials include a Post-doc in Bioengineering and Biomedical Engineering from EPFL and a Ph.D. in Mechanical Engineering from the University of Illinois Chicago.